Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
Natural Product Reports|June 11, 2020
Targeting eukaryotic proteases for natural products-based drug developmentFatma H Al-Awadhi, Hendrik LueschChembiochem : a European Journal of Chemical Biology|February 7, 2018
Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast CancerFatma H Al-Awadhi, Valerie J Paul, Hendrik LueschBioorganic & Medicinal Chemistry|May 24, 2016
Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacteriumFatma H Al-Awadhi, Ranjala Ratnayake, Valerie J Paul, et al.Journal of Natural Products|November 1, 2017
Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast CancerFatma H Al-Awadhi, Brian K Law, Valerie J Paul, et al.Journal of Natural Products|September 24, 2024
Isolation and Characterization of the Cyanobacterial Macrolide Glycoside Moorenaside, an Anti-Inflammatory Analogue of Aurisides Targeting the Keap1/Nrf2 PathwayFatma H Al-Awadhi, Sofia Kokkaliari, Ranjala Ratnayake, et al.Marine Drugs|September 21, 2017
Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast CancerFatma H Al-Awadhi, Lilibeth A Salvador, Brian K Law, et al.Marine Drugs|November 24, 2023
Discovery and Anti-Inflammatory Activity of a Cyanobacterial Fatty Acid Targeting the Keap1/Nrf2 PathwayFatma H Al-Awadhi, Emily F Simon, Na Liu, et al.ACS Chemical Neuroscience|June 20, 2020
Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS DiseasesFatma H Al-Awadhi, Lilibeth A Salvador-Reyes, Lobna A Elsadek, et al.Journal of Medicinal Chemistry|July 18, 2018
Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine CyanobacteriumFatma H Al-Awadhi, Bowen Gao, Mohammad A Rezaei, et al.ACS Medicinal Chemistry Letters|August 23, 2014
Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug PropertiesLilibeth A Salvador, Heekwang Park, Fatma H Al-Awadhi, et al.Pageof 19